US equities |
NVDA $238.90 ▲+2.12% SPCX $171.09 ▲+7.63% MU $1,063.96 ▼-1.02% TSLA $378.73 ▲+2.20% WBD $30.95 ▲+0.03% MSFT $525.18 ▲+1.48% AAPL $332.89 ▼-0.24% META $741.90 ▲+1.90%
FinancialContent

Articles published by Infinimmune

News headline image
Fierce Biotech, a division of Forge, names Infinimmune a “Fierce 15” Biotech Company of 2026
From Infinimmune
Via Business Wire
News headline image
Infinimmune Raises $75 Million Series A Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease
From Infinimmune
Via Business Wire
News headline image
Infinimmune Appoints Srikanth Pendyala, M.D., as Chief Medical Officer
From Infinimmune
Via Business Wire
News headline image
Infinimmune Appoints Anthony Slavin, Ph.D., as Senior Vice President of Portfolio Strategy
From Infinimmune
Via Business Wire
News headline image
Infinimmune Enters Collaboration with Merck to Discover Novel Human Antibody Therapeutics
From Infinimmune
Via Business Wire
News headline image
Infinimmune Announces Research Collaboration with Immunome
From Infinimmune
Via Business Wire
Tickers IMNM
News headline image
Infinimmune Launches GLIMPSE-1 AI Model Trained Exclusively on Human Antibody Sequences for Advanced Therapeutic Engineering
From Infinimmune
Via Business Wire
News headline image
Infinimmune Appoints Dr. Tim Sullivan as Chief Business Officer
From Infinimmune
Via Business Wire
News headline image
Infinimmune Appoints Dr. Neela Patel to Board of Directors
From Infinimmune
Via Business Wire
News headline image
Infinimmune Announces Partnership with Grid Therapeutics to Conduct Deep Sequencing of B Cells for Oncology Drug Discovery
From Infinimmune
Via Business Wire
News headline image
Infinimmune Raises $12 Million in Seed Funding to Pioneer Novel Approach to Antibody Drug Discovery and Development
From Infinimmune
Via Business Wire